about
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development.Prophylactic mastectomy: why and when?Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?Comparison of in vitro breast cancer visibility in analyser-based computed tomography with histopathology, mammography, computed tomography and magnetic resonance imaging.Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer.High-resolution CT by diffraction-enhanced x-ray imaging: mapping of breast tissue samples and comparison with their histo-pathology.Quantitative comparison between two phase contrast techniques: diffraction enhanced imaging and phase propagation imaging.Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth.
P50
Q33330850-4A628C7C-76C0-4738-BD6A-3C39E3F87251Q33901605-5AF2F493-FBA5-476F-92C9-4C578B8FC885Q35755362-0741BCCA-E5D3-4BEB-A142-BCC17EBA2D73Q37346276-C2551F7F-6053-465D-AD4F-D9B597FD2C6DQ39714858-A17BFD14-0113-4A58-93AD-4CA9E396DB67Q40168283-A79ED624-E6E1-4022-BDBB-BFF42A1E9FA4Q40227554-0235996E-D1FE-4EB9-AE2E-30E533C3BF3EQ40437406-1ECBF995-07B7-45BB-BCAB-C04E5FA3C290Q41528278-48AE3BA1-7F9F-43BD-BD41-EFE10F07C6E8
P50
description
Vuoden 2012 kunnanvaltuutettu, professor, kirurg
@fi
politicus
@nl
name
Karl von Smitten
@ast
Karl von Smitten
@en
Karl von Smitten
@es
Karl von Smitten
@fi
Karl von Smitten
@nl
Karl von Smitten
@sl
Karl von Smitten
@sv
type
label
Karl von Smitten
@ast
Karl von Smitten
@en
Karl von Smitten
@es
Karl von Smitten
@fi
Karl von Smitten
@nl
Karl von Smitten
@sl
Karl von Smitten
@sv
prefLabel
Karl von Smitten
@ast
Karl von Smitten
@en
Karl von Smitten
@es
Karl von Smitten
@fi
Karl von Smitten
@nl
Karl von Smitten
@sl
Karl von Smitten
@sv